INSIGHTS ON PHARMACEUTICAL PACKAGING

• The Benefits Of Late-Stage Customization For Orphan Drug Manufacturing

  Almac explains how, through the use of the Hapa BlisterJet printer, they are able to maximize the stock flexibility of their clients’ valuable orphan drug products, meaning they can distribute product more efficiently between different European countries.

• Clinical Trial Packaging, Labeling And Storage In Horsham, UK

  This video provides insight into Thermo Fisher Scientific’s primary and secondary packaging of clinical trial materials at the Horsham, UK site. This site also specializes in automated global distribution and in Cold Chain Management.

• PCI Activ-Blister Solutions

  Activ-Blister™ solutions provides product protection related to controlling humidity, oxygen, carbon dioxide, reactive impurities and odors. This market-leading technology was designed to actively control the internal atmosphere of individual blister cavities, without the use of purging, allowing for improved stability and enhanced shelf-life.

• Expanded Access And Commercial Packaging Strategies For Orphan, Niche, And Low-Volume Drugs

  Most commercial contract drug packagers do not provide consistent scheduling for low-volume drugs, which creates supply challenges. In fact, a drug packaging delay can create a market shortage that triggers serious health consequences for patients who rely on the drug. This issue can arise with niche and orphan drugs, as well as any other drugs packaged in small volumes. Conversely, a clinical supply partner can provide packaging as needed, plus handle distribution for expanded access and general commercial needs. This summary describes low-volume drugs, examines commercial packaging and supply challenges, and explores potential solutions.

• Current Trends In Medical Kit Packaging

  Today’s version of the medical procedure kit comprises stackable, efficient, sterile, and identifiable trays or pouches stocked with essential equipment for specific surgeries, tests, and examinations. 

• 8 mm Needle – Improving Subcutaneous Chronic Drug Delivery

  This paper describes how reducing needle length can improve the risk profile of subcutaneous injections and can make injecting viscous formulations easier and quicker, and highlights BD’s development programme for an innovative shorter needle with ultra-thin walls for prefilled syringes.

• Fit For Purpose Reagents - Packaging

  This video describes some of the tube and bottle choices available for custom products.

• Inline Weighing Technology Offers Additional Quality Check Features

  Protina Pharmazeutische GmbH produces high-quality preparations, such as medicine, food supplements and cosmetics. Alongside weight monitoring, the checkweigher used at Protina offers other important functions that support the company's system of strict quality management.

• The Value Of A BD Integrated System For Combination Products

  The growing complexity and regulatory rigour of combination products has called for increasingly innovative delivery devices. This article looks at the advantages of using an integrated system for these drug-device combination products rather than sourcing components from different suppliers.